Literature DB >> 11104212

The DYT1 GAG deletion is infrequent in sporadic and familial writer' s cramp.

C Kamm1, M Naumann, J Mueller, N Mai, L Riedel, J Wissel, T Gasser.   

Abstract

A 3-base pair (GAG) deletion in the DYT1 gene has recently been found to be responsible for most cases of early-onset primary generalized dystonia. In some cases, this mutation has been associated with writer's cramp. To determine the frequency of this mutation in a larger series of patients, we examined 44 index patients with sporadic or familial (seven patients) writer's cramp for the presence of the DYT1 GAG deletion, including eight patients with segmental dystonia involving at least one upper limb. We found the mutation in none of these index patients, which confirms that isolated writer's cramp is only in rare cases a phenotypic manifestation of this mutation, even if a positive family history of writer's cramp is present.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104212     DOI: 10.1002/1531-8257(200011)15:6<1238::aid-mds1027>3.0.co;2-z

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  3 in total

Review 1.  Early onset torsion dystonia (Oppenheim's dystonia).

Authors:  Christoph Kamm
Journal:  Orphanet J Rare Dis       Date:  2006-11-27       Impact factor: 4.123

2.  The Frequency of DYT1 (GAG Deletion) Mutation in Primary Dystonia Patients from Iran.

Authors:  Mohammad Hamid; Mohammad Taghi Akbari; Gholam Ali Shahidi; Zahra Zand
Journal:  Cell J       Date:  2011-04-21       Impact factor: 2.479

3.  High-throughput mutational analysis of TOR1A in primary dystonia.

Authors:  Jianfeng Xiao; Robert W Bastian; Joel S Perlmutter; Brad A Racette; Samer D Tabbal; Morvarid Karimi; Randal C Paniello; Andrew Blitzer; Sat Dev Batish; Zbigniew K Wszolek; Ryan J Uitti; Peter Hedera; David K Simon; Daniel Tarsy; Daniel D Truong; Karen P Frei; Ronald F Pfeiffer; Suzhen Gong; Yu Zhao; Mark S LeDoux
Journal:  BMC Med Genet       Date:  2009-03-11       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.